Irina Vlasova

Dr. Irina Vlasova

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2018 in Molecules
Verified
Journal Article
Open access
PDF file
IVIrina Vlasova
Irina Vlasova
The heme in the active center of peroxidases reacts with hydrogen peroxide to form highly reactive intermediates, which then oxidize simple substances called peroxidase substrates. Human peroxidases can be divided into two groups: (1) True peroxidases are enzymes whose main function is to generate free radicals in the peroxidase cycle and (pseudo)hypohalous acids in the halogenation cycle. The major true peroxidases are myeloperoxidase, eosinophil peroxidase and lactoperoxidase. (2) Pseudo-peroxidases perform various important functions in the body, but under the influence of external conditions they can display peroxidase-like activity. As oxidative intermediates, these peroxidases produce not only active heme compounds, but also protein-based tyrosyl radicals. Hemoglobin, myoglobin, cytochrome c/cardiolipin complexes and cytoglobin are considered as pseudo-peroxidases. Рeroxidases play an important role in innate immunity and in a number of physiologically important processes like apoptosis and cell signaling. Unfavorable excessive peroxidase activity is implicated in oxidative damage of cells and tissues, thereby initiating the variety of human diseases. Hence, regulation of peroxidase activity is of considerable importance. Since peroxidases differ in structure, properties and location, the mechanisms controlling peroxidase activity and the biological effects of peroxidase products are specific for each hemoprotein. This review summarizes the knowledge about the properties, activities, regulations and biological effects of true and pseudo-peroxidases in order to better understand the mechanisms underlying beneficial and adverse effects of this class of enzymes.

1 October 2012 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
IVIrina Vlasova
Irina Vlasova
TVTatyana V. Vakhrusheva
Tatyana V. Vakhrusheva
Alexey SokolovAlexey Sokolov
Alexey Sokolov
VKValeria Kostevich
Valeria Kostevich
AGAlexandr A. Gusev
Alexandr A. Gusev
ALAnatolii S. Lobach
Anatolii S. Lobach

1 August 2013 in Toxicology Letters
Verified
Journal Article
Closed access
TVTatyana V. Vakhrusheva
Tatyana V. Vakhrusheva
AGAlexandr A. Gusev
Alexandr A. Gusev
SGSergey A. Gusev
Sergey A. Gusev
IVIrina Vlasova
Irina Vlasova

1 January 2012 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
IVIrina Vlasova
Irina Vlasova
Alexey SokolovAlexey Sokolov
Alexey Sokolov
JAJuergen Arnhold
Juergen Arnhold

1 August 2016 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
IVIrina Vlasova
Irina Vlasova
EMElena V. Mikhalchik
Elena V. Mikhalchik
NBNikolay Barinov
Nikolay Barinov
VKValeria Kostevich
Valeria Kostevich
NSNatalia V. Smolina
Natalia V. Smolina
Alexey SokolovAlexey Sokolov
Alexey Sokolov

30 November 2017 in Bioelectromagnetics
Verified
Journal Article
Closed access
IVIrina Vlasova
Irina Vlasova
EMElena V. Mikhalchik
Elena V. Mikhalchik
AGAlexandr A. Gusev
Alexandr A. Gusev
NBNadezhda Georgievna Balabushevich
Nadezhda Georgievna Balabushevich
SGSergey A. Gusev
Sergey A. Gusev
KKKonstantin D. Kazarinov
Konstantin D. Kazarinov